Skip to main content
. 2022 Jul 2;40(7):699–714. doi: 10.1007/s40273-022-01168-0

Table 8.

Disease outcomes

Proportion of patients (%) Molnupiravir (%) Best supportive care (%)
Total alive, acute phase 99.88 98.71
Total dead, acute phase 0.12 1.29
Proportion hospitalized 6.38 9.20
Proportions in those who were alive at the end of the acute phase, by highest level of care
Outpatient 93.62 90.80
General ward 4.84 6.32
Intensive care unit 0.87 1.15
Mechanical ventilation 0.55 0.43
Proportions in those who died at the end of the acute phase, by highest level of care
General ward 0.02 0.14
Intensive care unit 0.04 0.43
Mechanical ventilation 0.06 0.72
Proportion readmitted 1.20 1.47
Proportions of those who survived the acute phase and experienced long-term sequelae, by highest level of care
Outpatient 41.12 39.88
General ward 3.71 4.84
Intensive care unit 0.85 1.12
Mechanical ventilation 0.52 0.41